Results 181 to 190 of about 836,777 (260)

Survival Outcomes in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Progression-Related Endpoints. [PDF]

Cancers (Basel)
Neculai-Candea LS, Caloian AD, Deacu S, Cristian M, Mazilu L, Ilie-Petrov AC, Nitu RA, Ciufu CA, Ciufu N.   +8 more
europepmc   +1 more source

Correction to "Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Immunogenic cell death as a mechanism of synergy between sunitinib and ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors. [PDF]

Cell Death Discov
Essler M, Veit N, Müller A, Marinova M, Kreppel B.   +4 more
europepmc   +1 more source

Pancreatic neuroendocrine tumor

, 2021
openaire   +1 more source

Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1. [PDF]

J Neuroendocrinol
Kozlov SV, Agarwal SK, Guerin TM, Lawrence WC, Bassel LL, Graf A, Jha S, Weinstein LS, Blau JE, Del Rivero J.   +9 more
europepmc   +1 more source

Serotonin Expression and β-Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology. [PDF]

J Surg Oncol
Windon AL, Revetta F, Chen W, Shi C.
europepmc   +1 more source

Pancreatic neuroendocrine tumour

, 2020
openaire   +1 more source

Pancreatic neuroendocrine tumor

, 2020
openaire   +2 more sources

Expression of ATRX, DAXX, PDX1, ARX, and somatostatin receptors in pancreatic neuroendocrine tumors: a clinicopathological study. [PDF]

Front Endocrinol (Lausanne)
Ciobanu OA, Martin CS, Fica S, Herlea V, Tudose I, Vasilescu F, Sandra I, Barbu CG.   +7 more
europepmc   +1 more source

Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression. [PDF]

Adv Sci (Weinh)
Jiang J, Wang Y, Qin Y, Chen L, Xu X, Fan G, Jing D, Wei M, Yu X, Xu J, Ji S, Chen J.   +11 more
europepmc   +1 more source